Clinical Trial Update: The Role and Mechanism of TCR-T Cells in Immunotherapy for Acute Myeloid Leukemia [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial update describing the role and mechanism of TCR-T cell therapy in Acute Myeloid Leukemia, with the study status marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• TCR-T cell therapy (T-cell receptor-engineered T cells)

Snippet

Sponsor: Shenzhen University General Hospital | Conditions: Acute Myeloid Leukemia (AML) | EARLY_Phase 1 | Status: COMPLETED